Transarterial Radioembolization versus Transarterial Chemoembolization Plus Percutaneous Ablation for Unresectable, Solitary Hepatocellular Carcinoma of =3 cm: A Propensity Score-Matched Study.

Transarterial Radioembolization versus Transarterial Chemoembolization Plus Percutaneous Ablation for Unresectable, Solitary Hepatocellular Carcinoma of =3 cm: A Propensity Score-Matched Study. J Vasc Interv Radiol. 2022 12; 33(12):1570-1577.e1.

View in: PubMed

subject areas

Carcinoma, Hepatocellular
Catheter Ablation
Chemoembolization, Therapeutic
Humans
Liver Neoplasms
Propensity Score
Retrospective Studies
Treatment Outcome

authors with profiles

Osmanuddin Ahmed
Thuong G. Van Ha
Rakesh Navuluri